132 related articles for article (PubMed ID: 8633812)
1. Efficacy dose determination study of tilmicosin phosphate in feed for control of pneumonia caused by Actinobacillus pleuropneumoniae in swine.
Moore GM; Mowrey DH; Tonkinson LV; Lechtenberg KF; Schneider JH
Am J Vet Res; 1996 Feb; 57(2):220-3. PubMed ID: 8633812
[TBL] [Abstract][Full Text] [Related]
2. Clinical field trials with tilmicosin phosphate in feed for the control of naturally acquired pneumonia caused by Actinobacillus pleuropneumoniae and Pasteurella multocida in swine.
Moore GM; Basson RP; Tonkinson LV
Am J Vet Res; 1996 Feb; 57(2):224-8. PubMed ID: 8633813
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of tilmicosin in the control of experimentally induced Actinobacillus pleuropneumoniae infection in swine.
Paradis MA; Vessie GH; Merrill JK; Dick CP; Moore C; Charbonneau G; Gottschalk M; MacInnes JI; Higgins R; Mittal KR; Girard C; Aramini JJ; Wilson JB
Can J Vet Res; 2004 Jan; 68(1):7-11. PubMed ID: 14979429
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the efficacy of tilmicosin phosphate to eliminate Actinobacillus pleuropneumoniae from carrier pigs.
Fittipaldi N; Klopfenstein C; Gottschalk M; Broes A; Paradis MA; Dick CP
Can J Vet Res; 2005 Apr; 69(2):146-50. PubMed ID: 15971680
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of tilmicosin phosphate (Pulmotil premix) in feed for the treatment of a clinical outbreak of Actinobacillus pleuropneumoniae infection in growing-finishing pigs.
Hoflack G; Maes D; Mateusen B; Verdonck M; de Kruif A
J Vet Med B Infect Dis Vet Public Health; 2001 Nov; 48(9):655-64. PubMed ID: 11765801
[TBL] [Abstract][Full Text] [Related]
6. Experimental infections with Actinobacillus pleuropneumoniae in pigs--II. Comparison of antibiotics for oral strategic treatment.
Wallgren P; Segall T; Pedersen Mörner A; Gunnarsson A
Zentralbl Veterinarmed B; 1999 May; 46(4):261-9. PubMed ID: 10379236
[TBL] [Abstract][Full Text] [Related]
7. Effects of oral administration of tilmicosin on pulmonary inflammation in piglets experimentally infected with Actinobacillus pleuropneumoniae.
Nerland EM; LeBlanc JM; Fedwick JP; Morck DW; Merrill JK; Dick P; Paradis MA; Buret AG
Am J Vet Res; 2005 Jan; 66(1):100-7. PubMed ID: 15691043
[TBL] [Abstract][Full Text] [Related]
8. [The effectiveness of tilmicosin in respiratory diseases of swine].
Binder S; Le NB; Berner H; Bauer J
Berl Munch Tierarztl Wochenschr; 1993 Jan; 106(1):6-9. PubMed ID: 8431202
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial activity of tilmicosin against Pasteurella multocida and Actinobacillus pleuropneumoniae isolated from pneumonic lesions in swine.
Inamoto T; Kikuchi K; Iijima H; Kawashima Y; Nakai Y; Ogimoto K
J Vet Med Sci; 1994 Oct; 56(5):917-21. PubMed ID: 7865594
[TBL] [Abstract][Full Text] [Related]
10. Efficacy evaluations of the use of oral tilmicosin in pneumonic calves.
Fodor L; Reeve-Johnson L; Hodge A; Varga J
Vet J; 2000 Mar; 159(2):194-200. PubMed ID: 10712808
[TBL] [Abstract][Full Text] [Related]
11. Comparison of pharmacokinetics of tilmicosin in healthy pigs and pigs experimentally infected with
Xiong J; Zhu Q; Yang S; Zhao Y; Cui L; Zhuang F; Qiu Y; Cao J
N Z Vet J; 2019 Sep; 67(5):257-263. PubMed ID: 31208293
[No Abstract] [Full Text] [Related]
12. Effect of subclinical infection with Actinobacillus pleuropneumoniae in commingled feeder swine.
Rohrbach BW; Hall RF; Hitchcock JP
J Am Vet Med Assoc; 1993 Apr; 202(7):1095-8. PubMed ID: 8473222
[TBL] [Abstract][Full Text] [Related]
13. Characterization of an Actinobacillus pleuropneumoniae seeder pig challenge-exposure model.
Lechtenberg KF; Shryock TR; Moore G
Am J Vet Res; 1994 Dec; 55(12):1703-9. PubMed ID: 7887514
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of enteric-coated tilmicosin granules in pigs artificially infected with Actinobacillus pleuropneumoniae serotype 2.
Dong Z; Zhou XZ; Sun JC; Meng XB; Li HS; Cheng FS; Wei XJ; Li B; Wang WW; Zhang JY
Vet Med Sci; 2020 Feb; 6(1):105-113. PubMed ID: 31589010
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of florphenicol premix in weanling pigs experimentally infected with Actinobacillus pleuropneumoniae.
Palacios-Arriaga JM; Gutierrez-Pabello JA; Chavez-Gris G; Hernandez-Castro R
Rev Latinoam Microbiol; 2000; 42(1):27-33. PubMed ID: 10948826
[TBL] [Abstract][Full Text] [Related]
16. Experimental infections with Actinobacillus pleuropneumoniae in pigs--I. Comparison of five different parenteral antibiotic treatments.
Wallgren P; Segall T; Pedersen Mörner A; Gunnarsson A
Zentralbl Veterinarmed B; 1999 May; 46(4):249-60. PubMed ID: 10379235
[TBL] [Abstract][Full Text] [Related]
17. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Actinobacillus pleuropneumoniae from pigs.
Blackall PJ; Asakawa T; Graydon RJ; White M; Adamson M; Wade LK; Lowe LB
Aust Vet J; 1995 Jan; 72(1):35-6. PubMed ID: 8787526
[No Abstract] [Full Text] [Related]
18. Clinical efficacy of carprofen as an adjunct to the antibacterial treatment of bovine respiratory disease.
Elitok B; Elitok OM
J Vet Pharmacol Ther; 2004 Oct; 27(5):317-20. PubMed ID: 15500569
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of tilmicosin in the control of experimental Mycoplasma gallisepticum infection in chickens.
Kempf I; Reeve-Johnson L; Gesbert F; Guittet M
Avian Dis; 1997; 41(4):802-7. PubMed ID: 9454912
[TBL] [Abstract][Full Text] [Related]
20. Efficacy evaluation of the use of oral tilmicosin in pneumonic calves.
Huwyler U; Reeve-Johnson L; Korfitsen J; Liesegang A; Wanner M
Schweiz Arch Tierheilkd; 1999; 141(4):203-8. PubMed ID: 10228400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
